Vitamin Shoppe, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2018 12 months to Dec 29, 2018	FY2017 12 months to Dec 30, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 26, 2015	FY2014 12 months to Dec 27, 2014
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization of fixed and intangible assets
Impairment charges on goodwill
Nutri-Force
Total impairment charges on goodwill
Impairment charges on intangible assets
Impairment charges on fixed assets
Contingent consideration for acquisition of FDC Vitamins, LLC
Nutri-Force
FDC Vitamins, LLC
Total contingent consideration for acquisition of FDC Vitamins, LLC

Loss on sale of FDC Vitamins, LLC
Amortization of deferred financing fees
Gain on extinguishment of debt
Amortization of debt discount on convertible notes
Deferred income taxes
Deferred rent
Equity compensation expense
Issuance of shares for services rendered
Tax benefits on exercises of stock options
Tax benefits on exercises of equity awards
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Other long-term assets
Accounts payable
Deferred sales
Accrued expenses and other current liabilities
Other long-term liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Capital expenditures
Acquisition of FDC Vitamins, LLC
FDC Vitamins, LLC
Total acquisition of FDC Vitamins, LLC

Acquisition of business
Net proceeds on sale of FDC Vitamins, LLC
Trademarks and other intangible assets
Net cash used in investing activities

Cash flows from financing activities:
Borrowings under revolving credit facility
Repayments of borrowings under revolving credit facility
Proceeds from issuance of convertible notes
Debt issuance costs on convertible notes
Bond hedge purchase
Proceeds from sale of warrants
Purchases of convertible notes
Bank overdraft
Payments of capital lease obligations
Proceeds from exercises of common stock options
Issuance of shares under employee stock purchase plan
Purchases of treasury stock
Purchases of shares under Share Repurchase Programs
Purchases of shares under Accelerated Share Repurchase Program
Tax benefits on exercises of stock options
Tax benefits on exercises of equity awards
Deferred financing fees and other
Net cash used in financing activities

Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents beginning of year
Cash and cash equivalents end of year
Supplemental disclosures of cash flow information:
Interest paid
Income taxes (refunded) paid
Supplemental disclosures of non-cash investing activities:
Liability for purchases of property and equipment
Assets acquired under capital leases
Assets acquired under tenant incentives

Comments